Mark Hamilton
The University of Texas MD Anderson Cancer Center(US)Multiple Myeloma Research Foundation(US)Stanford University(US)
Publications by Year
Research Areas
Multiple Myeloma Research and Treatments, CAR-T cell therapy research, Protein Degradation and Inhibitors, Chemokine receptors and signaling, Lymphoma Diagnosis and Treatment
Most-Cited Works
- → Post-infusion CAR TReg cells identify patients resistant to CD19-CAR therapy(2022)230 cited
- → Integrative pathway enrichment analysis of multivariate omics data(2020)228 cited
- → Systemic Fate of the Adipocyte-Derived Factor Adiponectin(2009)196 cited
- → Risk of Second Tumors and T-Cell Lymphoma after CAR T-Cell Therapy(2024)169 cited
- → Determinants of resistance to engineered T cell therapies targeting CD19 in large B cell lymphomas(2022)122 cited
- → Discovery and SAR of Novel 2,3‐Dihydroimidazo[1,2‐c]quinazoline PI3K Inhibitors: Identification of Copanlisib (BAY 80‐6946)(2016)113 cited